{"id":"https://openalex.org/W42967080","doi":null,"title":"[Substance use disorders and ADHD: an overview of recent Dutch research].","display_name":"[Substance use disorders and ADHD: an overview of recent Dutch research].","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W42967080","mag":"42967080","pmid":"https://pubmed.ncbi.nlm.nih.gov/24242145"},"language":"nl","primary_location":{"id":"pmid:24242145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24242145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tijdschrift voor psychiatrie","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024194782","display_name":"Katelijne van Emmerik\u2010van Oortmerssen","orcid":"https://orcid.org/0000-0002-0019-4584","observed_orcids":["https://orcid.org/0000-0002-0019-4584"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K van Emmerik-van Oortmerssen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030665207","display_name":"Cleo Lina Crunelle","orcid":"https://orcid.org/0000-0002-8798-0448","observed_orcids":["https://orcid.org/0000-0002-8798-0448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C L Crunelle","raw_affiliation_strings":["Faculty of Medicine and Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine and Pharmacy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066586770","display_name":"P.J. Carpentier","orcid":"https://orcid.org/0000-0002-6684-2847","observed_orcids":["https://orcid.org/0000-0002-6684-2847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P J Carpentier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3968,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.62892056,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":96},"biblio":{"volume":"55","issue":"11","first_page":"861","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.8880000114440918},{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":1.0},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.6700000166893005},{"id":"https://openalex.org/keywords/psychiatric-comorbidity","display_name":"psychiatric comorbidity","score":0.843999981880188},{"id":"https://openalex.org/keywords/dopamine-transporter-availability","display_name":"dopamine transporter availability","score":0.8830000162124634},{"id":"https://openalex.org/keywords/neurobiology-of-adhd","display_name":"neurobiology of ADHD","score":0.5910000205039978},{"id":"https://openalex.org/keywords/dutch-research","display_name":"Dutch research","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.9159049391746521},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6296107172966003},{"id":"https://openalex.org/C2778903061","wikidata":"https://www.wikidata.org/wiki/Q17156814","display_name":"Methadone maintenance","level":3,"score":0.5950700044631958},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5945891737937927},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.550408661365509},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.5355007648468018},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4786016643047333},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.43128150701522827},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.42857247591018677},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.4172619879245758},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.3884143531322479},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.3755662441253662},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.34419649839401245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20820894837379456},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.09282591938972473}],"mesh":[{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:24242145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24242145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tijdschrift voor psychiatrie","raw_type":"English Abstract"},{"id":"mag:42967080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24242145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2726077023","https://openalex.org/W1556645184","https://openalex.org/W2578472132","https://openalex.org/W2130665793","https://openalex.org/W2595308464","https://openalex.org/W3020747347","https://openalex.org/W4315498826","https://openalex.org/W2887409050","https://openalex.org/W1974236262","https://openalex.org/W2210260719"],"abstract_inverted_index":{"BACKGROUND:":[0],"ADHD":[1,28,61,73,109,120,142,155,197,201,213],"is":[2,124,135,150],"an":[3,18],"important":[4],"risk":[5],"factor":[6],"for":[7,141,222],"the":[8,25,33,37,58,70,90,138,145,180,209,223],"development":[9],"of":[10,20,27,36,40,43,57,60,69,72,94,119,147,185,212,226],"substance":[11,146],"use":[12],"disorders":[13,78,174],"(SUD).":[14],"AIM:":[15],"To":[16],"provide":[17,218],"overview":[19],"recent":[21],"Dutch":[22],"research":[23],"into":[24],"prevalence":[26,59,71,118,134,156,161,211],"in":[29,62,79,88,107,121,195,200,214,228],"SUD":[30,64,122,215],"populations":[31],"and":[32,54,74,84,92,98,112,143,188,217],"neurobiological":[34],"substrate":[35],"reduced":[38,224],"effect":[39],"pharmacological":[41],"treatment":[42,101],"this":[44,229],"patient":[45,230],"group.":[46],"METHOD:":[47],"We":[48],"describe":[49],"three":[50],"studies:":[51],"a":[52,66,86,153,219],"meta-analysis":[53],"meta-regression":[55],"analysis":[56],"6689":[63],"patients;":[65],"cross-sectional":[67],"study":[68,87],"several":[75],"other":[76,158],"psychiatric":[77,173],"193":[80],"methadon":[81],"maintenance":[82,165],"patients,":[83,216],"finally":[85],"which":[89],"availability":[91,184],"occupation":[93,190],"dopamine":[95,186],"transporters":[96,187],"before":[97],"after":[99],"methylphenidate":[100,192,227],"were":[102,175,193],"measured":[103],"using":[104],"SPECT":[105],"scans":[106],"24":[108],"patients":[110,123,166,198,202],"with":[111,152],"without":[113,203],"cocaine":[114,149],"addiction.":[115],"RESULTS:":[116],"The":[117,160],"estimated":[125],"to":[126],"be":[127],"23.1%":[128],"(95%":[129],"confidence":[130],"interval":[131],"19.4-27.2).":[132],"This":[133],"influenced":[136],"by":[137,144,191],"diagnostic":[139],"instrument":[140],"abuse:":[148],"associated":[151],"lower":[154,183,189],"than":[157,199],"substances.":[159],"found":[162,194],"among":[163],"methadone":[164],"was":[167],"similar,":[168],"namely":[169],"24.9%;":[170],"additional":[171],"comorbid":[172],"also":[176],"frequently":[177],"present.":[178],"In":[179],"imaging":[181],"study,":[182],"cocaine-dependent":[196],"SUD.":[204],"CONCLUSION:":[205],"These":[206],"studies":[207],"confirm":[208],"high":[210],"possible":[220],"explanation":[221],"efficacy":[225],"population.":[231]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}